search
Back to results

Sucrose at Triage for Acute Gastroenteritis Episode in Children (STAGE)

Primary Purpose

Gastroenteritis Acute, Vomiting

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
sucrose
Standard rehydration solution
Sponsored by
Jocelyn Gravel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Gastroenteritis Acute focused on measuring children, sucrose, emergency department, triage

Eligibility Criteria

6 Months - 83 Months (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Children aged 6 months to 6 years. We will restrict to this age group to have a more homogenous group.
  • At least 3 non-bilious, non-bloody, vomiting in the last 24 hours
  • No other diagnostic more likely than acute viral gastroenteritis suspected at triage

Exclusion Criteria:

  • Severe dehydration (based on poor capillary refill or hypotension)
  • Hypoglycemia identified by the triage nurse (< 2,8 mmol)
  • Bilious or bloody vomiting
  • Chronic disease other than asthma
  • Previous inclusion in the study
  • Inability to obtain parental informed consent (language barrier, absence, etc.)

Sites / Locations

  • Sainte-Justine HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Sucrose

Control

Arm Description

The experimental arm will receive 1.5 ml/kg of the sucrose solution at triage (once). The composition of the homemade sucrose solution used in our emergency department is 3.5 g of table sugar (sucrose) mixed with 10 ml of diluted juice (see standard arm description) to obtain a solution with the same appearance as the standard arm.

This group will receive 1.5 mL/kg of diluted juice composed of juice (apple or orange) and water in equal proportion once at triage. This solution contains 0.05 g/ml of sucrose for a total of 0.075 g/kg of sucrose (eight times less than the intervention arm).

Outcomes

Primary Outcome Measures

Mean amount of tolerated oral rehydration in mL
The total amount of rehydration solution tolerated during the two hours following intervention. This will be the amount of solution absorbed by the child without vomiting. In case of vomiting, the amount of solution absorbed will be the amount of solution tolerated after vomiting. In the few situations when the children will be discharged from the ED before two hours, we will collect the amount of solution tolerated before discharge.

Secondary Outcome Measures

Number of participants who needed an observation
Patient who are not immediately discharged by the treating physician after the first evaluation
Number of participants with oral rehydration failure
Patient who need an intravenous rehydration during ED stay
Mean number of vomiting
Number of vomiting episode per patient during ED stay
Number of participants who received ondansetron
Number of patients who received ondansetron during ED stay
Mean length of stay
The time between the intervention and ED discharge
Mean length of stay after physician evaluation
The time between the first evaluation by a physician and ED discharge
Number of participants who had a return visit
return visit to the ED

Full Information

First Posted
May 6, 2022
Last Updated
October 24, 2022
Sponsor
Jocelyn Gravel
search

1. Study Identification

Unique Protocol Identification Number
NCT05378776
Brief Title
Sucrose at Triage for Acute Gastroenteritis Episode in Children
Acronym
STAGE
Official Title
Triage Administration of Sucrose for Gastroenteritis in Children; a Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Recruiting
Study Start Date
May 11, 2022 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Jocelyn Gravel

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Background: Acute viral gastroenteritis is a very common pediatric medical condition that results in a large number of emergency department (ED) visits. Fasting-induced ketosis has been suggested to contribute to nausea and vomiting in children with VGE. To date, there is no data on the impact of oral sucrose intake during oral rehydration. Objective: The aim of this study is to assess the impact of providing a sucrose solution at triage to young children with suspected acute viral gastroenteritis on the amount of rehydration solution intake in the first 2 hours. We will also assess the proportion of discharge after initial medical evaluation, the proportion of oral rehydration failure, the number of vomiting episodes per patient, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours. Methods: This study will be a double-blind randomized controlled trial. Recruitment will take place in a tertiary pediatric ED. Participants will be all children who present to the ED with suspected acute acute viral gastroenteritis with at least three vomiting in the previous 24 hours. The intervention will consist in giving 1.5 ml/kg of a sucrose solution composed of diluted juice with added table sugar (3.5g of sucrose/10 ml) compared with 1.5 ml/kg of diluted juice (0.5g of sucrose/10 mL, standard of care in our ED). Following that, all participants will be rehydrated with 15 mL of diluted juice every 15 minutes or more if tolerated. The primary outcome will be the amount of rehydration solution (ml) absorbed in the first two hours following intervention. Secondary outcomes will include disposition after initial medical evaluation, oral rehydration failure, the number of vomiting, ondansetron administration, the time between the intervention and ED discharge, the time between the first medical contact and ED discharge and return visits within 48 hours. The primary analysis will be the difference in the amount of tolerated oral rehydration between the two groups. Based on a preliminary study of children suffering from VGE, it was estimated that the recruitment of 238 participants would provide a power of 80% to identify a difference of 15 ml between the two groups. Expected results: We hope that this study will demonstrate that an oral sucrose solution given at triage to children presenting with symptoms compatible with acute acute viral gastroenteritis promotes oral hydration and consequently increases the total amount of rehydration solution tolerated by children.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gastroenteritis Acute, Vomiting
Keywords
children, sucrose, emergency department, triage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
It is a blinded study for participants, treating physician and statistician. However, for practical reasons and to minimize cost related to the study preparation, the research nurses/assistants will not be blinded to the treatment.
Allocation
Randomized
Enrollment
238 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Sucrose
Arm Type
Experimental
Arm Description
The experimental arm will receive 1.5 ml/kg of the sucrose solution at triage (once). The composition of the homemade sucrose solution used in our emergency department is 3.5 g of table sugar (sucrose) mixed with 10 ml of diluted juice (see standard arm description) to obtain a solution with the same appearance as the standard arm.
Arm Title
Control
Arm Type
Placebo Comparator
Arm Description
This group will receive 1.5 mL/kg of diluted juice composed of juice (apple or orange) and water in equal proportion once at triage. This solution contains 0.05 g/ml of sucrose for a total of 0.075 g/kg of sucrose (eight times less than the intervention arm).
Intervention Type
Dietary Supplement
Intervention Name(s)
sucrose
Intervention Description
The experimental arm will receive 1.5 ml/kg of the sucrose solution at triage (once). The composition of the homemade sucrose solution used in our emergency department is 3.5 g of table sugar (sucrose) mixed with 10 ml of water. For this double-blind study, we replaced water with diluted juice (see standard arm description) to obtain a solution with the same appearance as the standard arm. With the idea of correcting ketosis, we chose to provide the same amount of sugar as we do in hypoglycemia (0.4-0.5 g/kg of dextrose) to participants in the intervention group, which represents 1.5 ml/kg of the sucrose solution containing 0.4 g of sucrose/mL for a total of 0.6 g/kg of sucrose.
Intervention Type
Dietary Supplement
Intervention Name(s)
Standard rehydration solution
Intervention Description
This group will receive 1.5 mL/kg of diluted juice composed of juice (apple or orange) and water in equal proportion once at triage. This solution contains 0.05 g/ml of sucrose for a total of 0.075 g/kg of sucrose (eight times less than the intervention arm).
Primary Outcome Measure Information:
Title
Mean amount of tolerated oral rehydration in mL
Description
The total amount of rehydration solution tolerated during the two hours following intervention. This will be the amount of solution absorbed by the child without vomiting. In case of vomiting, the amount of solution absorbed will be the amount of solution tolerated after vomiting. In the few situations when the children will be discharged from the ED before two hours, we will collect the amount of solution tolerated before discharge.
Time Frame
2 hours after intervention
Secondary Outcome Measure Information:
Title
Number of participants who needed an observation
Description
Patient who are not immediately discharged by the treating physician after the first evaluation
Time Frame
2 hours
Title
Number of participants with oral rehydration failure
Description
Patient who need an intravenous rehydration during ED stay
Time Frame
6 hours
Title
Mean number of vomiting
Description
Number of vomiting episode per patient during ED stay
Time Frame
6 hours
Title
Number of participants who received ondansetron
Description
Number of patients who received ondansetron during ED stay
Time Frame
6 hours
Title
Mean length of stay
Description
The time between the intervention and ED discharge
Time Frame
24 hours
Title
Mean length of stay after physician evaluation
Description
The time between the first evaluation by a physician and ED discharge
Time Frame
24 hours
Title
Number of participants who had a return visit
Description
return visit to the ED
Time Frame
48 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
83 Months
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Children aged 6 months to 6 years. We will restrict to this age group to have a more homogenous group. At least 3 non-bilious, non-bloody, vomiting in the last 24 hours No other diagnostic more likely than acute viral gastroenteritis suspected at triage Exclusion Criteria: Severe dehydration (based on poor capillary refill or hypotension) Hypoglycemia identified by the triage nurse (< 2,8 mmol) Bilious or bloody vomiting Chronic disease other than asthma Previous inclusion in the study Inability to obtain parental informed consent (language barrier, absence, etc.)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Jocelyn Gravel, MD
Phone
15143454931
Ext
2559
Email
graveljocelyn@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Soha Rached-D'Astous, MD
Phone
15143454931
Email
soha.rached-dastous.med@ssss.gouv.qc.ca
Facility Information:
Facility Name
Sainte-Justine Hospital
City
Montreal
State/Province
Quebec
ZIP/Postal Code
H3T1C5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jocelyn Gravel, MD
Phone
514-345-4931
Ext
2559
Email
graveljocelyn@htmail.com
First Name & Middle Initial & Last Name & Degree
Fannie Péloquin, MD
Phone
514-345-4931
Email
fannie.peloquin@hotmail.com
First Name & Middle Initial & Last Name & Degree
Jocelyn Gravel, MD
First Name & Middle Initial & Last Name & Degree
Sarah Mousseau, MD
First Name & Middle Initial & Last Name & Degree
Fannie Péloquin, MD
First Name & Middle Initial & Last Name & Degree
Soha Rached-D'Astous, MD
First Name & Middle Initial & Last Name & Degree
Olivia Weill, MD

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Sucrose at Triage for Acute Gastroenteritis Episode in Children

We'll reach out to this number within 24 hrs